Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Filings indexed 662 across all filing types
Latest filing 2020-11-16 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
2020年限制性股票激励计划(草案)
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of a 2020 restricted stock incentive plan by 南微医学科技股份有限公司 (Nanwei Medical Technology Co., Ltd.). It includes extensive information about the stock incentive plan, including legal basis, scope, number of shares, allocation, vesting conditions, performance targets, and governance related to the plan. The document references relevant laws and regulations, the company's articles of association, and includes detailed tables and explanations about the incentive plan's structure and conditions. It is not a financial report, earnings release, or a simple announcement. It is a regulatory filing related to a stock-based compensation plan, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a proxy solicitation or voting results announcement. It is a formal disclosure document about a stock incentive plan, which is typically classified under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance disclosure about equity incentives.
2020-11-16 Chinese
2020年限制性股票激励计划实施考核管理办法
Remuneration Information Classification · 95% confidence The document is titled as the '2020 Restricted Stock Incentive Plan Implementation Assessment Management Measures' for 南微医学科技股份有限公司. It details the company's internal procedures for assessing performance related to a stock incentive plan, including assessment objectives, principles, scope, institutions, indicators, standards, procedures, and result management. It references company governance structures like the board and committees, but it is not a financial report, earnings release, or regulatory filing. It is a detailed internal management document related to stock incentive plans and performance assessment, which aligns with Remuneration Information filings that cover compensation and incentive plans for executives and key personnel. The document is 3102 characters long, which is relatively short but contains substantive content about the incentive plan and assessment criteria, not just an announcement or summary. Therefore, the best fitting category is Remuneration Information (DEF 14A).
2020-11-16 Chinese
北京金诚同达律师事务所关于南微医学2020年限制性股票激励计划(草案)之法律意见书
Regulatory Filings
2020-11-16 Chinese
关于召开2020年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2020 second extraordinary general meeting of shareholders for 南微医学科技股份有限公司. It includes information about the meeting date, voting methods, agenda items, shareholder registration, and proxy authorization. There is no financial data or report content, only procedural and meeting logistics information. The document is under 5,000 characters and serves as a formal announcement for the shareholder meeting rather than the meeting materials or results themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2020-11-16 Chinese
2020年限制性股票激励计划首次授予激励对象名单
Remuneration Information Classification · 95% confidence The document is a list of recipients for a restricted stock incentive plan, detailing the allocation of restricted stock to directors, senior management, core technical personnel, and other employees. It includes specific share quantities and percentages relative to total shares. This type of document is related to executive compensation and stock incentive plans, which falls under Remuneration Information filings. The document is not a full annual report, earnings release, or other financial report, but specifically details stock incentives for management and employees.
2020-11-16 Chinese
2020年限制性股票激励计划(草案)摘要公告
Remuneration Information Classification · 95% confidence The document is a detailed announcement regarding a 2020 restricted stock incentive plan (股权激励计划) for a company named 南微医学科技股份有限公司. It includes specifics about the stock incentive plan, such as the number of shares, the allocation to directors and employees, the pricing, vesting conditions, performance targets, and legal compliance. The document is not a financial report, earnings release, or management discussion, but rather a detailed disclosure about a stock-based compensation plan. This type of document fits best under the category of Remuneration Information (DEF 14A), which covers reports detailing compensation plans for executives and directors, including stock incentive plans. The document is lengthy and detailed, not a brief announcement or a simple voting result, so it is not a Proxy Solicitation or Voting Results announcement. Therefore, the classification is DEF 14A with high confidence.
2020-11-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.